BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26744310)

  • 21. Purification and genetic characterisation of the novel bacteriocin LS2 produced by the human oral strain Lactobacillus salivarius BGHO1.
    Busarcevic M; Dalgalarrondo M
    Int J Antimicrob Agents; 2012 Aug; 40(2):127-34. PubMed ID: 22739096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18.
    Heng NC; Haji-Ishak NS; Kalyan A; Wong AY; Lovric M; Bridson JM; Artamonova J; Stanton JA; Wescombe PA; Burton JP; Cullinan MP; Tagg JR
    J Bacteriol; 2011 Nov; 193(22):6402-3. PubMed ID: 22038965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a bacteriocin-producing
    Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM
    Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study.
    Di Pierro F; Zanvit A; Nobili P; Risso P; Fornaini C
    Clin Cosmet Investig Dent; 2015; 7():107-13. PubMed ID: 26491371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.
    Qi F; Chen P; Caufield PW
    Appl Environ Microbiol; 2001 Jan; 67(1):15-21. PubMed ID: 11133423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
    Yoo HJ; Jwa SK; Kim DH; Ji YJ
    Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety assessment of Streptococcus salivarius DB-B5 as a probiotic candidate for oral health.
    Li X; Fields FR; Ho M; Marshall-Hudson A; Gross R; Casser ME; Naito M
    Food Chem Toxicol; 2021 Jul; 153():112277. PubMed ID: 34004226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a marine-derived dextranase and its application to the prevention of dental caries.
    Jiao YL; Wang SJ; Lv MS; Jiao BH; Li WJ; Fang YW; Liu S
    J Ind Microbiol Biotechnol; 2014 Jan; 41(1):17-26. PubMed ID: 24197466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.
    Wescombe PA; Heng NC; Burton JP; Chilcott CN; Tagg JR
    Future Microbiol; 2009 Sep; 4(7):819-35. PubMed ID: 19722837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation.
    Wu CC; Lin CT; Wu CY; Peng WS; Lee MJ; Tsai YC
    Mol Oral Microbiol; 2015 Feb; 30(1):16-26. PubMed ID: 24961744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
    Wescombe PA; Upton M; Dierksen KP; Ragland NL; Sivabalan S; Wirawan RE; Inglis MA; Moore CJ; Walker GV; Chilcott CN; Jenkinson HF; Tagg JR
    Appl Environ Microbiol; 2006 Feb; 72(2):1459-66. PubMed ID: 16461700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse activity spectra of bacteriocin-like inhibitory substances having activity against mutans streptococci.
    Balakrishnan M; Simmonds RS; Tagg JR
    Caries Res; 2001; 35(1):75-80. PubMed ID: 11125201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Review of the Role of Probiotic Supplementation in Dental Caries.
    Sivamaruthi BS; Kesika P; Chaiyasut C
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1300-1309. PubMed ID: 32307660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of a Streptococcus mutans strain producing a novel bacteriocin.
    Hillman JD; Johnson KP; Yaphe BI
    Infect Immun; 1984 Apr; 44(1):141-4. PubMed ID: 6706403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms.
    Humphreys GJ; McBain AJ
    Lett Appl Microbiol; 2019 Apr; 68(4):303-312. PubMed ID: 30776138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and certain properties of a bacteriocin from Streptococcus mutans.
    Ikeda T; Iwanami T; Hirasawa M; Watanabe C; McGhee JR; Shiota T
    Infect Immun; 1982 Mar; 35(3):861-8. PubMed ID: 7068219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cariogenicity of the probiotic bacterium Lactobacillus salivarius in rats.
    Matsumoto M; Tsuji M; Sasaki H; Fujita K; Nomura R; Nakano K; Shintani S; Ooshima T
    Caries Res; 2005; 39(6):479-83. PubMed ID: 16251792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered dextranase from Streptococcus mutans enhances the production of longer isomaltooligosaccharides.
    Klahan P; Okuyama M; Jinnai K; Ma M; Kikuchi A; Kumagai Y; Tagami T; Kimura A
    Biosci Biotechnol Biochem; 2018 Sep; 82(9):1480-1487. PubMed ID: 29806555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-
    Juntarachot N; Sirilun S; Kantachote D; Sittiprapaporn P; Tongpong P; Peerajan S; Chaiyasut C
    PeerJ; 2020; 8():e10165. PubMed ID: 33240599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.
    Burton JP; Wescombe PA; Macklaim JM; Chai MH; Macdonald K; Hale JD; Tagg J; Reid G; Gloor GB; Cadieux PA
    PLoS One; 2013; 8(6):e65991. PubMed ID: 23785463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.